Structural Heart Disease Program
What is it?
Structural heart disease includes defects in the heart wall or chambers of the heart or the heart valves. Loyola is at the forefront of programs nationwide for using minimally invasive techniques for the evaluation and treatment of structural heart defects, with an expert team of cardiologists, congenital heart disease specialists and cardiovascular surgeons.
Cardiac closure devices may be used to treat the following conditions:
- Atrial septal defect (ASD): A hole in the wall separating the upper heart chambers (atria), allowing blood to flow between the left and right sides of the heart. This can lead to the mixture of oxygenated blood needed for circulation with de-oxygenated blood.
- Ventricle septal defect (VSD): A hole in the wall separating the lower heart chambers (ventricles), which may lead to left ventricular overload and possibly pulmonary hypertension due to blood passing between the two ventricles. This may be detected as a murmur.
- Patent foramen ovale (PFO): A hole between the upper chambers of the heart (atria), creating a flap or valvelike opening. This allows blood to flow between the right and left atria and thus bypass the lung’s filtering system, which may lead to the passage of clots. Patients usually have no symptoms.
- Patent ductus arteriosis (PDA): An opening between the pulmonary artery and the aorta, which can cause too much blood to flow through the heart and weaken the heart muscle, potentially causing heart failure.
- Cardiac arteriovenous malformation (AVM): An abnormal connection between the arteries and veins that can affect blood flow within the capillaries, which may in turn disrupt the functions of delivering oxygen and nutrients to the body.
The structural heart disease program also diagnoses and treats anomalies of the valves of the heart, including the aortic, mitral, pulmonic, tricuspid and melody valves.
The Loyola difference
Loyola is a nationally recognized leader in cardiac care. U.S. News & World Report ranked us 18th in the nation for cardiology and heart surgery in 2012, making this our 10th year in the top 50.
Learn more about our performance outcomes.